Skip to main content

Table 4 Bivariate logistic regression analysis of unsuppressed viral load among Adults on follow up of ART at selected public and private health facilities of Adama town, East shewa zone, oromia, Ethiopia, 2021

From: Predictors of unsuppressed viral load among adults on follow up of antiretroviral therapy at selected public and private health facilities of Adama town: unmached case-control study

Variable

Case

Control

COR

95% CI

P-value

Frequency (%)

Frequency (%)

Gender

 Male

58 (50%)

82 (35.5%)

1

  

 Female

58(50%)

149 (64.5%)

1.82

1.16-2.86

0.01

Age

 18-30 years

55 (47.4%)

72 (31.2%)

1

  

 31-45 years

47 (40.5%)

115(49.8%)

1.869

1.147-3.045

.012

 46 -60 years

12 (10.3%)

37 (16%)

2.355

1.124-4.935

.023

 > 60 year

2 (1.7%)

(7 3%)

2.674

.534-13.378

.231

CD4 result (N = 253)

  < 100 cell/micro liter

26 (22.4%)

18 (7.8%)

.204

.101-.414

.000

 100-200 cell/micro liter

25 (21.6%)

26 (11.3%)

.307

.158-.596

.000

 > 200 cell/micro liter

36 (31%)

122 (52.8%)

1

  

Adherence level

 Good

82 (70.7%)

221(95.7%)

1

  

 Fair

13 (11.2%)

2 (0.87%)

1.57

1.32-5.86

0.000

 Poor

21 (18.1%)

8 (3.5%)

1.41

1.60-8.32

0.000

Disclosure of sero-status

 Yes

81(69.8%)

136 (58.9%)

1

  

 No

35 (30. 2%)

95 (41.1%)

.608

.378-.977

.040

BMI

  < 18 kg/m2

26(22.4%)

59 (25.5%)

1

  

 18.5-25 kg/m2

88 (75.9%)

153 (66.2%)

.208

.022-1.951

.169

 > 25 kg/m2

2 (1.7%)

19(8.2%)

.281

.032-2.440

.250

History of OI

 Yes

28 (24.1%)

42(18.2%)

1.432

.834-2.459

.193

 No

88 (73.9%)

189(81.8%)

1

  

History of chronic Gastritis problem

 Yes

8 (6.9%)

26 (11.3%)

0.584

.256-1.334

0.202

 No

108 (93.1%)

205 (88.7%)

1

  

Type of health facility

 Government

80(69%)

178(77.1%)

1

  

 Private

36(31%)

53(22.9%)

1.51

.918-2.489

.105

Level of Health facility

 Hospital

64(55.2%)

104(45%)

1

  

 Health center

52(44.8%)

127(55%)

.665

.425-1.042

0.075

Adverse effect of drug

 Yes

5(4.3%)

22(9.5%)

1

  

 No

111(95.7%)

209(89.5%)

.428

.158-1.161

.096

Duration on ART in month

  < 24 month

10(8.6%)

36(15.6%)

1

  

 24-48 month

28(24.8%)

73(31.6%)

.724

.724-.317

.443

 > 48 month

78((67.2%)

122(52.8%)

.434

.434-.204

.031

History of drug substitution

 Yes

84(72.4%)

146(63.2%)

1

  

 No

329(27.6%)

85(26.8%)

1.528

.939-2.487

.088

History of CPT use

 Yes

89(76.7%)

135(58.4%)

1

  

 No

27(23.3%)

96(42.6%)

2.344

1.416-3.88

.001

History of IPT used

 Yes

75(64.7%)

171(74%)

1

  

 No

41(35.3%)

60(26%)

.642

.397-1.038

.071

History of treatment interruption

 Yes

33(28.4%)

33(14.3%)

1

  

 No

83(72.6%)

19(85.7%)

2.386

1.381-4.120

.002

  1. Abbreviations: CD4 Cluster Differentiation, BMI Body Mass Index, OI Opportunistic Infection, ART Antiretroviral therapy, CPT Co-trimoxazole therapy, IPT Isonized Preventive Therapy, COR Crude Odd ratio, CI Confidence Interval